文献速递泌尿生殖腹部MR

多参数磁共振成像在前列腺癌检出与管理中的使用量急剧增加

Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer.
PubMed 文献 · Abdom Radiol (NY) · 2017-01-01

本研究回顾性分析了一家机构四百万患者数据库中2013年10月至2015年12月所有接受前列腺多参数MRI的男性临床资料,共1521例次,26个月内使用量增加486%。最常见指征为筛查异常(64%),其中47%随后行前列腺穿刺活检(认知融合65%、MRI-超声融合靶向35%),261例在泌尿外科医生充分告知后选择推迟穿刺。作者认为多参数MRI正越来越多地用于前列腺癌诊断和管理,有潜力影响临床决策。

要点

  • 前列腺多参数MRI使用量在26个月内增加486%,共完成1521例次。
  • 最常见指征为筛查异常(64%),其中47%后续行前列腺穿刺活检。
  • 活检方式中认知融合占65%,MRI-超声融合靶向占35%。

核心结论

  • 前列腺多参数MRI正越来越多地用于前列腺癌的诊断和管理,随着技术普及和放射学专业知识的扩散,多参数MRI有潜力影响临床决策并满足对无创、准确诊断和管理工具的需求。

研究设计与样本

  • 回顾性审查一家机构四百万患者的临床数据仓库,所有接受前列腺多参数MRI的男性临床信息于2013年10月至2015年12月收集于前瞻性设计的数据库中,并对每位患者进行个体病历审查。

诊断标准与关键数值

  • 共完成1521例次前列腺多参数MRI,26个月内使用量增加486%。
  • 多参数MRI最常见指征为筛查异常(64%),其中47%随后行前列腺穿刺活检,活检方式为认知融合(65%)或MRI-超声融合靶向(35%)。
  • 261例男性在与泌尿外科医生充分知情决策后选择推迟前列腺穿刺活检。
  • 12.7%的多参数MRI用于主动监测,7.5%用于临床分期,3.2%由放射肿瘤科医生用于放疗计划。
  • 7%的多参数MRI用于评估盆腔生化复发,其中三分之一识别出可用于靶向的可疑区域。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Multiparametric MRI (mpMRI) of the prostate is an evolving technology that provides functional information of the prostate that helps distinguish benign from malignant lesions. We hypothesized that mpMRI is rapidly adopted in the US to fill the unmet need for a non-invasive, accurate screening tool. The aim of this study is to assess the increasing utilization of mpMRI for the diagnosis and management of prostate cancer.

METHODS: We conducted a retrospective review of an institutional clinical data repository of four million patients. Clinical information from all men undergoing mpMRI from October 2013 to December 2015 was collected in a prospectively designed database. Individual chart reviews were performed for each patient.

RESULTS: 1521 mpMRI of the prostate were performed with an increase in the use of 486% over 26 months. The most common indication for mpMRI was abnormal screening (64%) and 47% of these men went on to prostate biopsy, either by cognitive mapping (65%) or MRI-US fusion targeting (35%). 261 men elected to defer prostate needle biopsy after informative decision-making with their urologist. 12.7% of mpMRI were performed for active surveillance, 7.5% for clinical staging, and 3.2% by radiation oncologists planning radiotherapy. 7% of mpMRI were performed to evaluate the pelvis for biochemical recurrence, a third of which identified a region of suspicion for targeted.

CONCLUSION: Prostate mpMRI is increasingly performed for both the diagnosis and management of prostate cancer. As clinical utilization increases along with the diffusion of technology and radiologic expertise, MpMRI has the potential to influence clinical decision-making and fulfill the need for a non-invasive, accurate tool for the diagnosis and management of prostate cancer.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Oberlin DT, Casalino DD, Miller FH, et al. Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer. Abdom Radiol (NY). 2017. PMID: 27858090. doi:10.1007/s00261-016-0975-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。